Organon Pharmaceuticals USA, Inc. engages in developing and producing prescription medicines for gynecology, psychiatry, cardiovascular disease, immunology, and anesthesia. The company is based in ...
Articles - 100s of articles on many topics CEUs & Training - Sources & recommendations Coding Support - Sources & recommendations Events - Webinars, Seminars, Conferences FAQs - Frequently Asked Questions Marketplace - Recommended products & services News - Industry news & Find-A-Code updates Webinars - 30-60 Minute Presentations Video Tutorials - Learn more about Find-A-Code
The Food and Drug Administration (FDA) is withdrawing approval of 67 new drug applications (NDAs) and 128 abbreviated new drug applications (ANDAs) from multiple applicants.
All information on this site is provided "as-is" for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health.
Organon USA Inc., is located at Roseland, NJ and serves the healthcare needs of people around the globe. Our primary focus has been and continues to be centered on the pursuit of therapeutic advances through a significant investment in R & D.
NEXPLANON- etonogestrel implant Organon USA Inc.-----HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively.
NUVARING- etonogestrel and ethinyl estradiol insert, extended release Organon USA Inc.-----HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively.
Organon was a pharmaceutical company headquartered in Oss, Netherlands.In November 2007, Schering-Plough Corporation, based in New Jersey, USA, acquired Organon, active pharmaceutical ingredient producer Diosynth (separate from Organon until 2004), and its veterinary pharmaceutical sister company Intervet from Akzo Nobel.